Basic Information
ID: ALA4135245
Type: Functional
Description: Antiviral activity against HIV1 infected in human P4R5 cells assessed as reduction in viral infection preincubated with cells for 24 hrs followed by viral infection measured after 48 hrs by fluorescence based beta-galactosidase reporter gene based MAGI assay
Organism: Human immunodeficiency virus 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4135245
EC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 184.18 | -0.01 | -0.01 |
| 198.20 | 0.30 | 0.30 |
| 260.27 | 1.66 | 1.66 |
| 444.42 | 0.91 | 0.91 |
| 254.25 | 1.59 | 1.59 |
| 305.79 | 0.06 | 0.06 |
| 260.27 | 1.66 | 1.66 |
| 294.72 | 2.31 | 2.31 |
| 294.72 | 2.31 | 2.31 |
| 367.86 | 1.24 | 1.24 |
| 226.26 | 0.52 | 0.52 |
| 288.69 | 2.25 | 2.25 |
| 240.28 | 0.91 | 0.91 |
| 278.26 | 1.79 | 1.79 |
| 253.26 | 2.27 | 2.27 |
| 311.77 | 0.82 | 0.82 |
| 274.30 | 1.58 | 1.58 |
| 242.21 | 0.00 | 0.00 |
| 212.23 | 0.61 | 0.61 |
| 322.18 | -0.67 | -0.67 |
| 260.27 | 1.66 | 1.66 |